GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pure Extracts Technologies Corp (FRA:PUX) » Definitions » Net-Net Working Capital

Pure Extracts Technologies (FRA:PUX) Net-Net Working Capital : €-0.03 (As of Mar. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Pure Extracts Technologies Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Pure Extracts Technologies's Net-Net Working Capital for the quarter that ended in Mar. 2023 was €-0.03.

The industry rank for Pure Extracts Technologies's Net-Net Working Capital or its related term are showing as below:

FRA:PUX's Price-to-Net-Net-Working-Capital is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.93
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Pure Extracts Technologies Net-Net Working Capital Historical Data

The historical data trend for Pure Extracts Technologies's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pure Extracts Technologies Net-Net Working Capital Chart

Pure Extracts Technologies Annual Data
Trend Jun21 Jun22
Net-Net Working Capital
- -0.02

Pure Extracts Technologies Quarterly Data
Sep19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.02 -0.02 -0.02 -0.03

Competitive Comparison of Pure Extracts Technologies's Net-Net Working Capital

For the Drug Manufacturers - Specialty & Generic subindustry, Pure Extracts Technologies's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pure Extracts Technologies's Price-to-Net-Net-Working-Capital Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pure Extracts Technologies's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Pure Extracts Technologies's Price-to-Net-Net-Working-Capital falls into.



Pure Extracts Technologies Net-Net Working Capital Calculation

Pure Extracts Technologies's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Jun. 2022 is calculated as

Net-Net Working Capital(A: Jun. 2022 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.082+0.75 * 0.138+0.5 * 1.066-2.836
-0-0)/108.85
=-0.02

Pure Extracts Technologies's Net-Net Working Capital (NNWC) per share for the quarter that ended in Mar. 2023 is calculated as

Net-Net Working Capital(Q: Mar. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.049+0.75 * 0.034+0.5 * 0.826-3.675
-0-0)/116.767
=-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Pure Extracts Technologies  (FRA:PUX) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Pure Extracts Technologies Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Pure Extracts Technologies's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Pure Extracts Technologies (FRA:PUX) Business Description

Traded in Other Exchanges
N/A
Address
7341 Industrial Way, Unit 6, Pemberton, BC, CAN, V0N 2K0
Pure Extracts Technologies Corp is a plant-based extraction company. The company specializes in the processing of cannabis, hemp and functional mushrooms to produce oils and various derivative products. Also, the company is involved in white labelling activities as well as selling branded oil-based products. It has three operating segments, the extraction and processing of cannabis and hemp, the development and commercialization of functional wellness products including psychedelic medicinal products, and its head office.

Pure Extracts Technologies (FRA:PUX) Headlines

No Headlines